NCT03661502

Brief Summary

Randomized controlled trial comparing low inspiratory and expiratory flow during variable volume ventilation with a constant volume decelerating flow (pressure controlled volume guarantee) ventilation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
1.1 years until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

May 29, 2019

Status Verified

May 1, 2019

Enrollment Period

1.2 years

First QC Date

September 4, 2018

Last Update Submit

May 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of lung recruitments required to keep dynamic lung compliance above 40.

    Measuring dynamic lung compliance during mechanical ventilation. When it drops below 40 a lung recruitment is done with increase of PEEP to maximum 15 cmH2O.

    during mechanical ventilation under general anesthesia between 1 and 3 hours. No outcome measurements are measured after 3 hours.

Secondary Outcomes (1)

  • Oxygen saturation at arrival of PACU without oxygen therapy.

    during stay in PACU being between 1 and 4 hours post operative of the same day. No outcome measurements are measured after 4 hours.

Study Arms (2)

variable tidal volume ventilation (VVV)

EXPERIMENTAL

the intervention is using a ventilation mode with variable tidal volume. The average tidal volume is 6 ml/kg and respiratory rate adapted to reach an end tidalCO2 concentration between 30 and 50 mmHg. Lung recruitment is given when dynamic lung compliance drops below 40. No drug is given. No other treatment or intervention is given.

Device: VVV

Pressure controlled ventilation (PCV)

EXPERIMENTAL

the intervention is using ventilation mode with constant pressure and constant tidal volume. The tidal volume is 6 ml/kg and respiratory rate is adapted to reach end tidal CO2 concentrations between 30 and 50 mmHg. Lung recruitment is given when dynamic lung compliance drops below 40. No drug is given. No other treatment or intervention is given.

Device: PCV

Interventions

VVVDEVICE

ventilation mode with variable tidal volume is chosen. the average tidal volume is 6 ml/kg and respiratory rate adapted to reach end tidal con between 30 and 50 mmHg

variable tidal volume ventilation (VVV)
PCVDEVICE

ventilation mode with constant tidal volume is chosen. the tidal volume is 6 ml/kg and respiratory rate adapted to reach end tidal con between 30 and 50 mmHg

Pressure controlled ventilation (PCV)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • laparoscopic bariatric surgery requiring mechanical ventilation

You may not qualify if:

  • lung disease requiring oxygen before anesthesia
  • emergence procedure
  • spontaneous or assisted ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azsintjan

Bruges, 8000, Belgium

Location

MeSH Terms

Conditions

Lung Injury

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesThoracic InjuriesWounds and Injuries

Study Officials

  • Marc Lanckneus

    AZ Sint-Jan AV

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
head of dep anesthesia & intensive care

Study Record Dates

First Submitted

September 4, 2018

First Posted

September 7, 2018

Study Start

October 1, 2019

Primary Completion

December 1, 2020

Study Completion

December 1, 2022

Last Updated

May 29, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations